Skip to Main Content

1,282

Views

0

CrossRef citations to date

0

Altmetric

Original Research

Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen

Josiah Rymana Quantitative Pharmacology and Pharmacometrics, Merck & Co Inc, Rahway, NJ, USAView further author information

,

Jeffrey R. Sachsa Quantitative Pharmacology and Pharmacometrics, Merck & Co Inc, Rahway, NJ, USAView further author information

,

Natalie Banniettisb Clinical Research, Merck & Co., Inc, Rahway, NJ, USAView further author information

,

Thomas Weissc Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USAView further author information

,

Maurice Ahsmana Quantitative Pharmacology and Pharmacometrics, Merck & Co Inc, Rahway, NJ, USAView further author information

,

Ka Lai Yeea Quantitative Pharmacology and Pharmacometrics, Merck & Co Inc, Rahway, NJ, USAView further author information

&

Jessica Weaverc Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USACorrespondence[email protected]
View further author information